{"id":"tp-54350","type":"article-newspaper","title":"Autolus Raises 2026 AUCATZYL Revenue Outlook to at Least $150 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54350","datePublished":"2026-11-11T19:05:49.000Z","dateModified":"2026-11-11T19:05:49.000Z","language":"en","abstract":"Third-quarter net product revenue increased 95% year over year to $41.2 million. Initial BOBCAT data in progressive multiple sclerosis is planned for October 2027.","section":"Business","references":[]}